Christophe Van Steenkiste

Author

Also Known As

C Van Steenkiste, C van Steenkiste, C. VAN STEENKISTE, C. Van Steenkiste, Christophe Van Steenkiste, Christophe Van Steenkiste, Christophe van Steenkiste, Mary Crow, Steenkiste, Christophe Van, Van Steenkiste, Christophe

166

Publications

3.7K

Citations

H-Index

Concepts

All Affiliations

Ghent University Hospital Ghent University AZ Maria Middelares University of Antwerp Antwerp University Hospital

About

Christophe Van Steenkiste is an author at Ghent University Hospital specializing in medicine, hepatology, and liver physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	1.1K
2	Health Sciences	5	5	564
3	Cell Biology	4	4	212
4	Biochemistry	2	2	39
5	Biomedical Engineering	1	1	39

Christophe Van Steenkiste

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue, Journal of Hepatology FibrosisHepatologyLiver PhysiologyClinical TrialsPathology	2020	438
Further Pharmacological and Genetic Evidence for the Efficacy of PlGF Inhibition in Cancer and Eye Disease Sara Van de Veire, Ingeborg Stalmans, Femke Heindryckx, Cell Ocular DiseaseEye DiseaseOphthalmologyPlgf InhibitionMedicine	2010	252
Increased intrahepatic resistance in severe steatosis: endothelial dysfunction, vasoconstrictor overproduction and altered microvascular architecture Sven Francque, Wim Laleman, Len Verbeke, Laboratory Investigation	2012	132
Angiopoietin‐2 Promotes Pathological Angiogenesis and Is a Therapeutic Target in Murine Nonalcoholic Fatty Liver Disease Sander Lefere, Frederique Van de Velde, Anne Hoorens, Hepatology	2018	129
Role of vascular endothelial growth factor in the pathophysiology of nonalcoholic steatohepatitis in two rodent models Stéphanie Coulon, Vanessa Legry, Femke Heindryckx, Hepatology	2013	97
Inhibition of placental growth factor activity reduces the severity of fibrosis, inflammation, and portal hypertension in cirrhotic mice Christophe Van Steenkiste, Jordi Ribera, Anja Geerts, Hepatology Human GrowthImmunologyPathologyFetal GrowthInflammation	2011	87
Modulation of the unfolded protein response impedes tumor cell adaptation to proteotoxic stress: a PERK for hepatocellular carcinoma therapy Yves‐Paul Vandewynckel, Debby Laukens, Eliene Bogaerts, Hepatology International	2014	70
Role of Placental Growth Factor in Mesenteric Neoangiogenesis in a Mouse Model of Portal Hypertension Christophe Van Steenkiste, Anja Geerts, Eline Vanheule, Gastroenterology AngiogenesisDevelopmental BiologyPlacental Growth FactorPortal HypertensionPathology	2009	61
Placental growth factor inhibition targets pulmonary angiogenesis and represents a therapy for hepatopulmonary syndrome in mice† Sarah Raevens, Anja Geerts, Annelies Paridaens, Hepatology	2017	58
Serum vascular cell adhesion molecule-1 predicts significant liver fibrosis in non-alcoholic fatty liver disease Sander Lefere, Frederique Van de Velde, Lindsey Devisscher, International Journal of Obesity InflammationMetabolic SyndromeFibrosisMetabolic Associated SteatohepatitisHepatology	2017	51

Page 1